Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2013 - New Market Report
Global Markets Direct's, 'Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Juvenile Macular Degeneration (Stargardt Disease), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Juvenile Macular Degeneration (Stargardt Disease). Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, Half Year is built using data and information sourced...
View full press release